Failure of SGLT-2 inhibitor in the context of new ileal conduit formation

被引：0
|
作者：
Almog, Joel [1 ,4 ]
Jain, Shalu [2 ]
Pybass, Phillip [3 ]
Gupta, Ankur [1 ]
机构：
[1] Te Whatu Ora Hlth New Zealand Midcent Dist, Dept Nephrol, Hamilton, New Zealand
[2] Te Whatu Ora Hlth New Zealand Midcent Dist, Diabet & Endocrinol Serv, Hamilton, New Zealand
[3] Te Whatu Ora Hlth New Zealand Midcent Dist, Dept Internal Med, Hamilton, New Zealand
[4] Palmerston North Hosp, Ground Floor,50 Ruahine St, Palmerston North 4442, New Zealand
来源：
NEW ZEALAND MEDICAL JOURNAL | 2023年 / 136卷 / 1571期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 85
页数：3
相关论文
共 50 条
  • [21] Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
    Grempler, R.
    Thomas, L.
    Eckhardt, M.
    Himmelsbach, F.
    Sauer, A.
    Sharp, D. E.
    Bakker, R. A.
    Mark, M.
    Klein, T.
    Eickelmann, P.
    DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 83 - 90
  • [22] SGLT-2 inhibitors: new horizons for rheumatologists
    Chakrabarti, Katherine
    McCune, W. Joseph
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (05) : 351 - 359
  • [23] Effects Of Sglt-2 Inhibitor Use Among LVAD Patients
    Al Ali, Omar Tayseer
    Pendela, Venkata Satish
    Babayale, Omofolarin
    Faisaluddin, Mohammed
    Parikh, Vishal
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 205 - 205
  • [24] SGLT-2 inhibitor-associated euglycemic ketoacidosis in Denmark
    Johansson, Karl Sebastian
    Bogevig, Soren
    Christensen, Mikkel B.
    CLINICAL TOXICOLOGY, 2024, 62 : 117 - 117
  • [25] Causes of euglycemic Ketoacidosis under SGLT-2 Inhibitor Therapy
    Kahl, Sabine
    DIABETOLOGE, 2019, 15 (05): : 476 - 477
  • [26] Is GFR decline induced by SGLT-2 inhibitor of clinical importance?
    Guenes-Altan, M.
    Bosch, A.
    Striepe, K.
    Schiffer, M.
    Bramlage, P.
    Schmieder, R. E.
    Kannenkeril, D.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S352 - S352
  • [27] IS GFR DECLINE INDUCED BY SGLT-2 INHIBITOR OF CLINICAL IMPORTANCE?
    Guenes-Altan, Merve
    Bosch, Agnes
    Striepe, Kristina
    Schiffer, Mario
    Bramlage, Peter
    Schmieder, Roland E.
    Kannenkeril, Dennis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I87 - I88
  • [28] Heart failure: SGLT-2 inhibitors have multiple benefits
    Heinzl, Susanne
    DIABETES STOFFWECHSEL UND HERZ, 2024, 33 (04):
  • [29] The use of SGLT-2 inhibitors and hemoconcentration in patients with heart failure
    Demir, E.
    Kose, R.
    Pirmammadova, F.
    Unlugenc, H.
    Gurgun, C.
    Nalbantgil, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 219 - 220
  • [30] The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure
    Riggs, Kayla
    Ali, Hiba
    Taegtmeyer, Heinrich
    Gutierrez, Absalon D.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (07) : 292 - 297
12345